Yahoo
NSE - Free Realtime Quote INR

RPG Life Sciences Limited (RPGLIFE.NS)

2,637.90 +58.90 (+2.29%)
As of 1:56:14 PM GMT+5:30. Market Open.
Chart Range Bar
Loading chart for RPGLIFE.NS
  • Previous Close 2,579.00
  • Open 2,581.30
  • Bid 2,630.30 x --
  • Ask 2,638.30 x --
  • Day's Range 2,573.00 - 2,649.30
  • 52 Week Range 1,733.00 - 3,127.80
  • Volume 7,008
  • Avg. Volume 27,471
  • Market Cap (intraday) 43.628B
  • Beta (5Y Monthly) -0.05
  • PE Ratio (TTM) 39.76
  • EPS (TTM) 66.35
  • Earnings Date --
  • Forward Dividend & Yield 24.00 (0.93%)
  • 1y Target Est 3,205.00
  • Moby Rating Neutral

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

www.rpglifesciences.com

1,366

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

RPGLIFE.NS
14.71%
S&P BSE SENSEX (^BSESN)
5.26%

1-Year Return

RPGLIFE.NS
10.98%
S&P BSE SENSEX (^BSESN)
2.97%

3-Year Return

RPGLIFE.NS
89.85%
S&P BSE SENSEX (^BSESN)
24.54%

5-Year Return

RPGLIFE.NS
298.64%
S&P BSE SENSEX (^BSESN)
33.60%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY21
Revenue 971.3M
Earnings 111.5M
Profit Margin 11.48%

Q3

FY20

Q4

FY20

Q1

FY21

Q2

FY21

0
200M
400M
600M
800M
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

3,205.00
3,205.00 Average
2,637.90 Current
3,205.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.29%

  • Return on Assets (ttm)

    9.13%

  • Return on Equity (ttm)

    15.60%

  • Revenue (ttm)

    7.64B

  • Net Income Avi to Common (ttm)

    1.09B

  • Diluted EPS (ttm)

    66.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.92B

  • Total Debt/Equity (mrq)

    3.05%

  • Levered Free Cash Flow (ttm)

    -107.17M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: